P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 CASTOR TRIAL. (5th April 2022)

Record Type:: Journal Article
Title:: P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 CASTOR TRIAL. (5th April 2022)
Main Title:: P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 CASTOR TRIAL
Authors:: Sonneveld, P
Chanan-Khan, A
Weisel, K
Nooka, AK
Masszi, T
Beksac, M
Spicka, I
Hungria, V
Munder, M
Mateos, MV
Mark, TM
Levin, MD
Ahmadi, T
Qin, X
Garvin Mayo, W
Gai, X
Carey, J
Carson, R
Spencer, A
Abstract:
Is Part Of:: HemaSphere. Volume 6(2022)Supplement 2
Journal:: HemaSphere
Issue:: Volume 6(2022)Supplement 2
Issue Display:: Volume 6, Issue 2 (2022)
Year:: 2022
Volume:: 6
Issue:: 2
Issue Sort Value:: 2022-0006-0002-0000
Page Start:: 12
Page End:: 12
Publication Date:: 2022-04-05
Subjects:: Hematology -- Periodicals
616.15005
Journal URLs:: https://journals.lww.com/hemasphere/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1097/01.HS9.0000829588.31575.a9 ↗
Languages:: English
ISSNs:: 2572-9241
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21663.xml